Biomed Environ Sci, 2013; 26(3):

Similar documents
Holarctic distribution of Lyme disease

Seroprevalence of Babesia microti in Individuals with Lyme Disease. Sabino R. Curcio, M.S, MLS(ASCP)

Tickborne Disease Case Investigations

Recognizing the Clinical and Laboratory Presentation of Human Granulocytic Anaplasmosis

The Federal Tick-borne Disease Working Group and CDC's current activities on IPM for Lyme disease prevention and control

Lyme Disease. By Farrah Jangda

STATEMENT FOR MANAGING LYME DISEASE IN NOVA SCOTIA

Fatigue, persistence after Lyme borreliosis 196, 197 Francisella tularensis, see Tularemia

BlueBLOT-LINE Borrelia. Test Characteristics. Antibody Response

PRICE LIST Effective Date: October 16, 2017

Title: Revision of the National Surveillance Case Definition for Ehrlichiosis (Ehrlichiosis/Anaplasmosis)

Lyme Neuroborreliosis

Technical Bulletin No. 121

Infectious Diseases Expert Group (IDEG) Department of Health and Wellness. Statement for Managing Lyme Disease in Nova Scotia

WHAT WE KNOW ABOUT ANAPLASMOSIS AND BORRELIOSIS AND WHAT WE DO NOT A. Rick Alleman, DVM, PhD, DACVP, DABVP

Panel & Test Price List Effective Date: October 16, 2017

Normal Reference Value of Hemoglobin of Middleaged Women and Altitude

LYME DISEASE Last revised May 30, 2012

Nosocomial Transmission of Human Granulocytic Anaplasmosis in China

A Study of the Technique of Western Blot for Diagnosis of Lyme Disease caused by Borrelia afzelii in China *

Prospective Assesment of the Etiology of Acute Febrile Illness after a Tick Bite in Slovenia

290 Biomed Environ Sci, 2016; 29(4):

[1]. Therefore, determination of antibody titers is currently the best laboratory

Ring Forms in Red Blood Cells (RBCs) Babesia? from Danish Chronically Ill Patients, All Clinically Suspect of Having Persistent Active Borreliosis!

Serological Responses to Ehrlichia equi, Ehrlichia chaffeensis, and Borrelia burgdorferi in Patients from New York State

Serological evidence of infection. Uygur Autonomous Region area, Chi. Citation VETERINARY PARASITOLOGY, 134(3-4)

Lyme Disease Diagnosis and Treatment

Human granulocytic ehrlichiosis (HGE) was first

Anaplasma. Agent Searching a Disease

Analysis of main T-cell subsets and activated

Update on Lyme Disease Surveillance in Wisconsin for Providers and Laboratories

Lyme Disease, an Infectious Diseases Perspective

Lyme disease Overview

Lyme Disease. 1. DISEASE REPORTING A. Purpose of Reporting and Surveillance

Lyme Disease. Abstract Lyme disease is a vector borne infection primarily transmitted by Ixodes ticks and. Special Issue

Efficacy of antibiotic prophylaxis for the prevention of Lyme disease: an updated systematic review and meta-analysis

Utility of Borrelia burgdorferi sensu stricto C6 Peptide for Serologic Confirmation of Erythema-free Ixodid Tick-borne Borrelioses in Russia

Lyme disease Overview

3. THE GLOBAL PERSPECTIVE

Title: Public Health Reporting and National Surveillance for Babesiosis

Peter J. Weina, PhD, MD, FACP, FIDSA. Colonel, Medical Corps, US Army Deputy Commander Walter Reed Army Institute of Research

SELECTED INFECTIONS ACQUIRED DURING TRAVELLING IN NORTH AMERICA. Lin Li, MD August, 2012

Emerging vector-borne diseases in the United States: What s next and are we prepared?

Lyme Disease and Tick Surveillance in British Columbia

PE1662/E Lyme Disease Action submission of 27 October 2017

Department of Medical Microbiology, Faculty of Medicine, University of Malaya, Malaysia; 2

Ticks & Tickborne Diseases of Minnesota. Vectorborne Diseases Unit Last Updated February 16, 2018

Tick-borne Infections

Human Ehrlichiosis: A Case Study

Tick-borne Disease Surveillance

Humoral Immune Responses in Patients with Lyme Neuroborreliosis

Received 7 March 2002/Returned for modification 21 June 2002/Accepted 10 July 2002

A Clinical, Diagnostic, and Ecologic Perspective on Human Anaplasmosis in the Upper Midwest

Alberta Health Public Health Notifiable Disease Management Guidelines January 2013

Validation of Cultivation and PCR Methods for Diagnosis of Lyme Neuroborreliosis

Serodiagnosis of Human Granulocytic Ehrlichiosis by a Recombinant HGE-44-Based Enzyme-Linked Immunosorbent Assay

EQUINE GRANULOCYTIC ANAPLASMOSIS IN A NEW BRUNSWICK HORSE

Researches on Fermentation Engineering of Polysaccharide of

Persistence of Immunoglobulin M or Immunoglobulin G Antibody Responses to Borrelia burgdorferi Years after Active Lyme Disease

Abstract. Introduction

Leptospira interrogans causes leptospirosis, a usually mild febrile illness that may result in liver or kidney failure.

History of Lyme Disease

Two-Year Evaluation of Borrelia burgdorferi Culture and Supplemental Tests for Definitive Diagnosis of Lyme Disease

Public awareness of malaria at the beginning of a national malaria elimination program in China

UPDATE ON CANINE AND FELINE BLOOD DONOR SCREENING FOR BLOOD BORNE PATHOGENS Wardrop et al, JVIM 2016 Consensus statement

LU:research Institutional Repository of Lund University

Ehrlichiosis/Anaplasmosis

Current Trends and Research in Vector-Borne Disease in New York State

Phase IV clinical trial of Shufeng Jiedu Capsule in the treatment of cases of acute upper espiratory infection of wind-heat syndrome

Coastal California. migrans rash at least 5 cm in diameter or specific musculoskeletal, in California identified 399 autochthonous cases of Lyme

Manitoba Annual Tick-Borne Disease Report

2/5/19. Lyme Disease: It s Complicated! Lyme Disease is Worldwide. Lyme Disease: An Immune Response initiated by Borrelia burgdoferi

Using administrative medical claims data to estimate underreporting of infectious zoonotic diseases

Lyme disease in Canada: modelling,, GIS and public health action

Review Article Human Coinfection with Borrelia burgdorferi and Babesia microti in the United States

China HPAI Situation - Update

The Trouble with Ticks: Distribution, Burden, and Prevention of Tickborne Disease in Humans

Babesia microti, Human Babesiosis, and Borrelia burgdorferi

Manitoba Annual Tick-Borne Disease Report

Rapid Detection of Milk Protein based on Proteolysis Catalyzed by Trypsinase

PRESCRIBING INFORMATION. LYMErix TM Lyme Disease Vaccine (Recombinant OspA)

Corporate Medical Policy

LIMITING LYME DISEASE: USING SYSTEM DYNAMICS SIMULATION TO TARGET HEALTH INTERVENTIONS. Shilo Helen McBurney

Virginia Department of Health. Attached are the publications on ticks and tick-borne diseases from the Department of Health s website.

Corporate Leadership Forum March Briefing March 11, 2015

HUMAN PLAGUE OUTBREAK IN TWO VILLAGES, YUNNAN PROVINCE, CHINA, 2005

Western Blot Analysis for Diagnosis of Lyme Disease in Acute Facial Palsy

Malaria Situation and Control in China

EVALUATION OF LYME DISEASE TESTS. I would like to thank Dr. Dumler for his reply to my letter expressing concerns regarding

162 Biomed Environ Sci, 2014; 27(3):

Prevalence of diabetes and impaired fasting glucose in Uygur children of Xinjiang, China

Comparison of Different Strains of Borrelia burgdorferi Sensu Lato Used as Antigens in Enzyme-Linked Immunosorbent Assays

Supplementary Appendix

Genome-wide association study of esophageal squamous cell carcinoma in Chinese subjects identifies susceptibility loci at PLCE1 and C20orf54

Title: Public Health Reporting and National Notification for Lyme Disease

Avian Influenza A(H7N9) 13 February 2014 Surveillance Update

patients with Lyme disease often have antibodies that bind to spirochetes isolated

Strategic Paper: Outline

Climate Change as a Driver for Vector-Borne Disease Emergence

Transcription:

Biomed Environ Sci, 2013; 26(3): 185 189 185 Original Article Seroepidemiological Investigation of Lyme Disease and Human Granulocytic Anaplasmosis among People Living in Forest Areas of Eight Provinces in China * HAO Qin 1, GENG Zhen 1, HOU Xue Xia 1, TIAN Zhen 2, YANG Xiu Jun 3, JIANG Wei Jia 4, SHI Yan 5, ZHAN Zhi Fei 6, LI Guo Hua 7, YU De Shan 8, WANG Hua Yong 9, XU Jian Guo 1, and WAN Kang Lin 1,# 1. National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention; State Key Laboratory for Infectious Disease Prevention and Control, Beijing 102206, China; 2. Henan Oil Prospecting Bureau, Nanyang 473132, Henan, China; 3. Jilin Provincial Centre for Disease Control and Prevention, Changchun 130062, Jilin, China; 4. Guizhou Provincial Centre for Disease Control and Prevention, Guiyang 550004, Guizhou, China; 5. Qinghai Provincial Centre for Disease Control and Prevention, Xining 810007, Qinghai, China; 6. Hunan Provincial Centre for Disease Control and Prevention, Changsha 410005, Hunan, China; 7. Shanxi Provincial Centre for Disease Control and Prevention, Taiyuan 030012, Shanxi, China; 8. Gansu Provincial Centre for Disease Control and Prevention, Lanzhou 730000, Gansu, China; 9. Miyun Centre for Disease Control and Prevention, Beijing 101500, China Abstract Objective Lyme disease and Human granulocytic anaplasmosis are tick borne diseases caused by Borrelia burgdorferi and Anaplasma phagocytophilum respectively. We have investigated infection and co infection of the two diseases in the population of forest areas of eight provinces in China by measuring seroprevalence of antibodies against B. burgdorferi and A. phagocytophilum. Methods Forest areas in 8 provinces were chosen for investigation using whole sampling and questionnaire survey methods. 3 669 serum samples from people in the forest areas were tested for the presence of antibodies by indirect immunofluorescent assay (IFA). Results Seroprevalence against B. burgdorferi was 3% to 15% and against A. phagocytophilum was 2% to 18% in the study sites in the 8 provinces in China. We also found co infection of B. burgdorferi and A. phagocytophilum in 7 of the 8 provinces (the exception being the Miyun area in Beijing). The seroprevalence for both B. burgdorferi and A. phagocytophilum was significantly higher among people exposed to ticks than among people who were not exposed to ticks. Conclusion We conclude that both pathogens are endemic in the forest areas in the eight provinces, but the prevalence of B. burgdorferi and A. phagocytophilum differs between the provinces. Key words: Borrelia burgdorferi; Anaplasma phagocytophilum; Co infection; Residents of forest areas Biomed Environ Sci, 2013; 26(3):185 189 doi: 10.3967/0895 3988.2013.03.005 ISSN:0895 3988 www.besjournal.com(full text) CN: 11 2816/Q Copyright 2013 by China CDC INTRODUCTION L yme disease (LD), caused by Borrelia burgorferi, is a multisystem illness that primarily affects the skin, nervous system, heart, and joints [1 2]. Human granulocytic anaplasmosis (HGA), caused by Anaplasma phagocytophilum, has been recently recognized as an emerging tick borne disease [3 4]. Patients with HGA often present with nonspecific symptoms that * This research was supported by the 12th Five Year Major National Science and Technology Projects of China (No. 2012ZX10004219 007) and ( No. 2013ZX10004001). # Correspondence should be addressed to WAN Kang Lin. Tel:86 10 58900776. E mail: wankanglin@icdc.cn Biographical note of the first author: HAO Qin, female, born in 1975, Ph.D, majoring in Lyme disease. Received: September 15, 2011; Accepted: October 23, 2012

186 Biomed Environ Sci, 2013; 26(3): 185 189 include fever, myalgia, headache, chills, lethargy, arthralgia, leukopenia, and hematological abnormalities [5 6]. In China, Lyme disease has been studied since the 1980s. From 1987 to 1996, we carried out investigations on LD in 22 provinces in China [7]. Our investigations showed that LD is widely distributed in China with an average infection rate of 5.06% in the human population. Infection rates of forest people in the Northeast area, Inner Mongolia and Xinjiang Uygur Autonomous Region are over 10%. There are typical LD patients in many areas of China. We isolated more than 100 B. burgoferi strains from humans, animals and ticks and demonstrated that there are endemic foci in China. Despite the fact that the causative agent, A. phagocytophilum, is widely distributed in ticks and rodents around the country, human infection with HGA has only recently been reported in China [8 9], the first cases being described in Anhui Province in 2008 [8]. Seroprevalence of HGA has so far not been investigated in most areas of the country. In other countries co infection of Lyme disease with other pathogens such as A. phagocytophilum or Babesia has been frequently reported [11 12], but till now there are few reports of co infection of B. burgdorferi with other pathogens in China. In view of the wide variety of ecological environments and the many kinds of ticks found in China [13], we have investigated the seroprevalence of both Lyme disease and HGA among the human population in forest areas of 8 provinces in China, covering a wide area of the country from north to south. Human Population MATERIALS AND METHODS We chose forest areas in 8 provinces as investigation sites because of the clear evidence of ticks in these environments. The residents of the investigation sites were recruited by a whole sampling method. Criteria for inclusion were: (1) aged 5 years, (2) no history of leptospirosis or syphilis, and (3) had lived in the forest areas and often worked in the fields. One or two villages were chosen in each county of each province. The following sites were investigated: Changbai County and Tonghua County in Jilin Province; Huzhu northern forest area and Huangnan Maixiu forest area in Qinghai Province; Diebu County and Minle County in Gansu Province; Yuncheng area and Jiaocheng area in Shanxi Province; Shimen County and Liuyang area in Hunan Province; Daozhen County, Weining County, Songtao County and Jinping County in Guizhou Province; Miyun area in Beijing; Henan oil prospecting bureau in Henan Province. A questionnaire was designed for the investigation. The information collected included basic personal information, living environment, history of tick bites, work history and clinical symptoms. A total of 3 669 serum samples were collected from 1 398 females and 2 271 males (ranging in age from 5 to 75 years): 10.06% (369/3 669) belonged to the 20 age group, 72.80% (2 671/3 669) to the 20 50 age group and 17.14% (629/3 669) to the >50 years age group. All participants provided written informed consent to the study. Serological Tests 5 ml of venous blood was taken from the elbow vein of each participant in the morning prior to breakfast. Reaction to both anti A. phagocytophilum IgG antibodies and anti B. burgdorferi sensu lato IgG antibodies were detected by indirect immunofluorescence assay (IFA). Commercial kits with HL60 cells infected with a human isolate of A. phagocytophilum (Focus Technologies HGE IFA IgG Test Kit, Cypress, CA, USA) were used to test anti A. phagocytophilum IgG antibodies, the titer 1/64 being considered as positive according to the manufacturer s instruction. Antigen used to test anti B. burgdorferi s.l. IgG antibodies was prepared from a Chinese human B. garinii isolate, PD91. The PD91 isolate was cultivated in BSK II media at 33 C for a week, harvested and washed in phosphatebuffered saline. Antigen was spotted onto the wells of microtiter slides and fixed with acetone. A titer of 1/128 was considered positive [7]. All serum samples were screened at a concentration of 1/64 with A. phagocytophilum and B. burgdorferi. reactive with B. burgdorferi s. l. at 1/64 were tested at 1:128 and if reactive, at 1/128 were considered positive and not titrated further. Statistical analysis was performed using Pearson s χ 2 test and P<0.05 was considered significant. RESULTS Seroprevalence of A. phagocytophilum and B. burgdorferi Among 3 669 sera tested, 261 were positive against A. phagocytophilum, and 379 were positive

Biomed Environ Sci, 2013; 26(3): 185 189 187 against B. burgdorferi. Seroprevalence of A. phagocytophilum and B. burgdorferi differed significantly between the eight provinces (A. phagocytophilum: χ 2 =124.89, P<0.01; B. burgdorferi: χ 2 =32.73, P<0.01) (Table 1, Figure 1, Figure 2). Table 1. Seroprevalence of A. phagocytophilum and B. burgdorferi among People Who Live in the Forest Areas in 8 Provinces of China Areas B.burgdorferi(%) Jilin 469 35 (7.46) 43 (9.17) Qinghai 397 34 (8.56) 59 (14.86) Gansu 386 45 (11.66) 39 (10.10) Shanxi 397 70 (17.63) 22 (5.54) Hunan 321 23 (7.17) 27 (8.41) Guizhou 425 18 (4.24) 59 (13.88) Beijing 102 8 (7.84) 3 (2.94) Henan 1 172 28 (2.39) 127 (10.84) There were no differences in seroprevalence of antibodies to A. phagocytophilum and B. burgdorferi s. l. according to sex (A. phagocytophilum: χ 2 =2.33, P>0.05; B. burgdorferi: χ 2 =0.88, P>0.05) (Table 2). The infection rates of A. phagocytophilum were different according to age groups (χ 2 =19.12, P<0.01); however, there was no significant difference in the infection rate of B. burgdorferi according to age groups (χ 2 =2.14, P>0.05) (Table 3). Co infection of A. phagocytophilum and B. burgdorferi Among the sera from 7 of the provinces (excluding Beijing), 46 sera were positive for both A. phagocytophilum and B. burgdorferi as shown in Table 4. Table 2. Seroprevalence of A. phagocytophilum and B. burgdorferi of Different Gender Groups Sex B. burgdorferi(%) Male 2 271 150 (6.61) 243 (10.70) Female 1 398 111 (7.94) 136 (9.73) Table 3. Seroprevalence of A. phagocytophilum and B. burgdorferi of Different Age Groups Figure 1. The infection rate of AP in eight provinces. Age Group B. burgdorferi(%) 10 108 10 (9.26) 12 (11.11) ~20 261 28 (10.73) 21 (8.05) ~30 583 36 (6.17) 62 (10.63) ~40 1 258 76 (6.04) 137 (10.89) ~50 830 48 (5.78) 83 (10.00) >50 629 63 (10.02) 64 (10.17) Table 4. Co infection Rate of A. phagocytophilum and B. burgdorferi in Eight Provinces Figure 2. The infection rate of Bb in eight provinces. Study Sites Co infection Positive Rate (%) Jilin 469 5 1.07 Qinghai 397 18 4.53 Gansu 386 10 2.59 Shanxi 397 5 1.26 Hunan 321 2 0.62 Guizhou 425 3 0.71 Beijing 102 0 0.00 Henan 1 172 3 0.26 Total 3 669 46 1.25

188 Biomed Environ Sci, 2013; 26(3): 185 189 Infection of People Exposed to Ticks and People Unexposed to Ticks 404 sera of people exposed to ticks and 182 sera of people unexposed to ticks from Hunan and Shanxi provinces were tested to compare the infection rate of HGA. The infection rate of A. phagocytophilum was significantly different between the tick exposed population (16.58%, 67/404) and the non tick exposed population (9.89%, 18/182) (χ 2 =4.53, P<0.05). There was no significant difference between tick exposed (7.43%, 30/404) and non tick exposed (3.85%, 7/182) populations for infection rate of B. burgdorferi (χ 2 =2.72, P>0.05). DISCUSSION Both Lyme disease and human granulocytic anaplasmosis are emerging tick borne zoonosis. Because of similar risk factors and ecologic conditions, infection with B. burgorferi and A. phagocytophilum can occur at the same time and therefore are often examined together [14 15]. We investigated the prevalence of A. phagocytophilum and B. burgdorferi infection in people living in forest areas in eight provinces in China. Our data show that both A. phagocytophilum infection and B. burgdorferi infection occur among people in all the eight provinces, but the positive rates of A. phagocytophilum and B. burgorferi in eight provinces are very different. The positive rate for A. phagocytophilum is similar to the positive rate for B. burgdorferi in Gansu, Jilin, and Hunan; Qinghai, Guizhou and Henan have much higher prevalence for B. burgdorferi than A. phagocytophilum, whereas the prevalence for A. phagocytophilum is much higher than B. burgdorferi in Beijing and Shanxi. There are many possible reasons for these differences including prevalence of A. phagocytophilum and B. burgdorferi in ticks and human exposure to ticks. Therefore, further studies are needed to investigate the vectors and reservoirs, and their role in the transmission of A. phagocytophilum and B. burgdorferi in these areas. Previous studies show that Lyme disease is endemic in all 8 provinces investigated in this study [7,16 18]. However, the seropositivity rate to B. burgdorferi is higher in our study than previous studies in Gansu, Qinghai, and Guizhou. The high prevalence of B. burgdorferi in our study may have been because we biased our study towards people living or working in the forest areas. Except for Shanxi, seroprevalence to HGA had not previously been investigated in the other 7 provinces. We showed that seroprevalence to HGA occurs in all 8 provinces investigated. It suggests that HGA is widely distributed in China. Our investigation also showed co infection of A. phagocytophilum and B. burgorferi in seven of the investigated provinces. The co infection rate was highest in Qinghai (4.53%). Co infection may affect the process, the severity and the treatment and prognosis of the diseases [19 20]. More attention should therefore be paid to co infection of A. phagocytophilum and B. burgorferi. Our results showed that the infection rate of A. phagocytophilum among people exposed to ticks was higher than that of people unexposed to ticks in Hunan and Shanxi. However, there was no significant difference in seropositive rate of antibodies to B. burgorferi between the people exposed to ticks and the people unexposed to ticks. The insignificant differences of seroprevalence for Lyme disease among the population exposed to ticks and population unexposed to ticks may be caused by the small size of samples. The IFA method used in this survey was one of the standard serologic tests for LD, which can provide a useful result but its specificity remains unsatisfactory. It is therefore recommended that positive samples be tested further by other methods for definitive diagnosis of Lyme disease patients [21]. The results of our investigation show that infection with A. phagocytophilum and B. burgdorferi among people living in the forest areas in China is common. Our study should alert physicians in the investigated areas to the importance of diagnosis and treatment of Lyme disease and HGA. REFERENCES 1. Steere AC. Lyme disease. N Engl J Med, 1989; 321(9), 586 96. 2. Steere AC, Malawista SE, Hardin JA, et al. Erythema chronicum migrans and Lyme arthritis. The enlarging clinical spectrum. Ann Intern Med, 1977; 86(6), 685 98. 3. Chen SM, Dumler JS, Bakken JS, et al. Identification of a granulocytotropic Ehrlichia species as the etiologic agent of human disease. J Clin Microbiol, 1994; 32(3), 589 95. 4. Lotric Furlan S, Rojko T, Petrovec M, et al. Epidemiological, clinical and laboratory characteristics of patients with human granulocytic anaplasmosis in Slovenia. Wien Klin Wochenschr, 2006; 118(21 22), 708 13. 5. Brouqui P, Bacellar F, Baranton G, et al. Guidelines for the diagnosis of tick borne bacterial diseases in Europe. Clin Microbiol Infect, 2004; 10(12), 1108 32. 6. Bakken JS, Krueth J, Wilson Nordskog C, et al. Clinical and laboratory characteristics of human granulocytic ehrlichiosis.

Biomed Environ Sci, 2013; 26(3): 185 189 189 JAMA, 1996; 275(3), 199 205. 7. Zhang ZF, Wan KL, Zhang JS. Studies on epidemiology and etiology of Lyme disease in China. Chinese Journal of Epidemiology, 1997; 18(1), 8 11. (In Chinese) 8. Zhang L, Liu Y, Ni D, et al. Nosocomial transmission of human granulocytic anaplasmosis in China. JAMA, 2008; 300(19), 2263 70. 9. Cao WC, Zhao QM, Zhang PH, et al. Prevalence of Anaplasma phagocytophila and Borrelia burgdorferi in Ixodes persulcatus ticks from northeastern China. Am J Trop Med Hyg, 2003; 68(5), 547 50. 10. Cao WC, Zhan L, He J, et al. Natural Anaplasma phagocytophilum infection of ticks and rodents from a forest area of Jilin Province, China. Am J Trop Med Hyg, 2006; 75(4), 664 8. 11. Loebermann M, Fingerle V, Lademann M, et al. Borrelia burgdorferi and Anaplasma phagocytophilum coinfection. Emerg Infect Dis, 2006; 12(2), 353 5. 12. Abrams Y. Complications of coinfection with Babesia and Lyme disease after splenectomy. J Am Board Fam Med, 2008; 21(1), 75 7. 13. Wan K, Zhang Z, Dou G. Investigation on primary vectors of Borrelia burgdorferi in China. Chinese Journal of Epidemiology, 1998; 19(5), 263 6. (In Chinese) 14. Barthold SW, Persing DH, Armstrong AL, et al. Kinetics of Borrelia burgdorferi dissemination and evolution of disease after intradermal inoculation of mice. Am J Pathol, 1991; 139(2), 263 73. 15. Alekseev AN, Dubinina HV, Van De Pol I, et al. Identification of Ehrlichia spp. and Borrelia burgdorferi in Ixodes ticks in the Baltic regions of Russia. J Clin Microbiol, 2001; 39(6), 2237 42. 16. Cao WC, Zhao QM, Zhang PH, et al. Granulocytic Ehrlichiae in Ixodes persulcatus ticks from an area in China where Lyme disease is endemic. J Clin Microbiol, 2000; 38(11), 4208 10. 17. Wang DM, Hao Q, Cai XH, et al. Study on ribotyping of Lyme borreliosis spirochete in Guizhou province. Chinese Journal of Epidemiology, 2003; 24(12), 1129 31. (In Chinese) 18. Chu CY, Liu W, Jiang BG, et al. Novel genospecies of Borrelia burgdorferi sensu lato from rodents and ticks in southwestern China. J Clin Microbiol, 2008 Sep; 46(9), 3130 3. 19. Krause PJ, Telford SR, Spielman A, et al. Concurrent Lyme disease and babesiosis. Evidence for increased severity and duration of illness. JAMA, 1996; 275(21), 1657 60. 20. Ramsey AH, Belongia EA, Gale CM, et al. Outcomes of treated human granulocytic ehrlichiosis cases. Emerg Infect Dis, 2002; 8(4), 398 401. 21.Schwan TG, Burgdorfer W, Rosa PA. Borrelia. In: Murray PR, Baron EJ, Pfaller MA, Tenover FC, Yolken RH, editors. Manual of clinical microbiology. Washington: American Society for Microbiology, 1999; 746 58.